Clinical Trial Update: Aripiprazole Treatment of Prodromal Patients [Phase 2, Phase 3]

View source ↗

Summary

This document summarizes completed Phase 2/Phase 3 clinical trials evaluating aripiprazole for prodromal symptoms in schizophrenia and related psychosis. It pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Yale University | Conditions: Schizophrenia, Psychosis | Phase 2, Phase 3 | Status: COMPLETED